Global Liver Disease Treatment Market
The liver is one of the most important organs of the human body and performs major functions, such as removal of harmful substances from blood, maintains adequate level of chemicals in the body and stores nutrients for all cellular and biological activities. Improper functioning of liver cause many severe diseases, such as hepatitis A, B, C, Primary Biliary Cirrhosis and tumors. Some inherited diseases, such as Wilson’s Disease, Alagille Syndrome and Hemochromatosis are also occurred by improper functioning of liver. Some of the major reasons for improper functioning of liver are genetic disorder, excessive alcohol consumption and obesity. Some of these may also lead to permanent damage of liver.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/2831
The global market of liver disease treatment is categorized based on various drugs type and by disease. The drug type segment is further sub-segmented in vaccines, antiviral, corticosteroids, anabolic steroids, antimetabolites, anti-rejection drugs, immunosuppressive agents, immune globulins and chemotherapy. The antiviral drug represents the largest sub-segment in global liver disease treatment market. Moreover, the disease segment includes hepatitis, autoimmune diseases, liver tumor, alcohol induced liver disease, chronic liver disease and non-alcoholic fatty liver disease. The treatment of hepatitis is the largest and fastest growing sub-segment in global liver disease treatment market.
Under geographic analysis, North America is the largest market for liver disease treatment drugs followed by Europe and Asia. In North America, the U.S. represents the largest market for liver disease treatment drugs. In Europe, Germany, France and the U.K. covers the major share of liver disease treatment market. Moreover, Asia represents the fastest growing market for liver disease treatment drugs, due to increasing geriatric populations. The liver has a significant ability to regenerate and maintain function in elderly age. However, changes in cellular and physiological function during aging inhibit the normal function of the liver and cause diseases. Furthermore, Asia is one of the strong oncology markets accounting for nearly half of all new cancer cases in the world. These increasing cases of cancer also comprise liver cancers. This increasing number of liver cancer cases in the Asian countries requires huge amount of liver disease treatment drugs for prevention and treatment of liver cancer and tumors.
Globally, liver disease treatment market is growing with moderate growth rate due to aging population, excessive alcohol consumptions and increasing prevalence of liver diseases. Moreover, high unmet needs for the treatment of liver cancer also supports in growth of liver disease treatment market. However, side-effects and risk associated with medications impede growth of the liver disease treatment market. Moreover, stringent FDA approvals procedure and other government regulations also impede growth of the liver disease treatment market. Furthermore, availability of alternate treatment procedure is one of the key challenge for global liver disease treatment market.
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/2831
Some of the key companies operating in the liver disease treatment market are Abbott Laboratories, Actavis Inc., Aton Pharma, Bayer Schering AG, Biotest, Bristol-Myers Squibb, Eli Lilly, Forest laboratories, Inc., Glaxosmithkline PlC, Merck & Co., Mylan, Novartis, Pfizer, Roche, Sanofi-Aventis, Takeda Pharmaceuticals and Zydus Pharmaceuticals Inc.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Liver Disease Treatment Market here
News-ID: 479246 • Views: 312
More Releases from Persistence Market Research Pvt. Ltd
Global HPMC Capsules Market is expected to reach a Valuation of US$ 554.5 Mn Ove …
HPMC capsules are strictly non-toxic and qualify to be Kosher and Halal-certified, which is why their popularity has grown in several parts of the world. Moreover, these capsules can significantly boost the body metabolism by improving absorption and digestion of protein, fat and carbohydrates. HPMC capsules find their application in the preparation of non-animal based medicines and cosmetics & nutraceuticals products. Persistence Market Research (PMR) recently conducted a study
Vacuum Tissue Processor Technology Most Favored in the Global Tissue Processing …
Persistence Market Research has come up with a fact based analytical research study describing various aspects of the tissue processing systems market across the globe. The analysis on tissue processing systems has been systematically drafted in a new research publication titled “Tissue Processing Systems Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”. This comprehensive research report focuses on various developments, trends, restraints, opportunities, drivers and challenges impacting revenue growth of
Endodontics Market Is Projected To Grow At A Moderate CAGR During The Period Of …
Endodontics is associated with the dentistry segment. It involves several therapies to protect the human teeth from infections and injuries caused to the dental pulp. Generally, it is concerned with morphology, pathology as well as physiology of dental pulp and the periradicular tissues. Endodontics is important during carrying out root canal procedure in order to reduce the inflammation and to end infection. Modernization has touched the field of endodontics as
Global Home Infusion Therapy Devices Market Driven by Growing Incidence of Pain, …
According to the latest market report published by Persistence Market Research titled ‘Home Infusion Therapy Devices Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),’ the global Home Infusion Therapy Devices market is expected to expand at a CAGR of 6.8% during the forecast period 2017–2025. Persistence Market Research delivers key insights and presents a revised forecast of the global Home Infusion Therapy Devices market for an eight year period from
More Releases for Asia
Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario. Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256 The Asia-Pacific IVD market is
RAMPF Korea – Producing in Asia for Asia
Joint Venture for the Asian markets – The international RAMPF Group has realigned the cooperation with its long-standing partner Orient Dosiertechnik from Korea with the founding of RAMPF Korea Co., Ltd. The new company based in Hwaseong City is developing and producing mixing and dispensing systems specifically for the Asian markets. Within the framework of the new joint venture based in Hwaseong City, mixing and dispensing systems are being developed and
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022. 23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property
MES: Expansion in Asia
Berlin, November 24, 2014: Model Engineering Solutions (MES), the Berlin-based specialist for model-based software development, has significantly expanded its business in Asia. In recent years, MES has built up a network of local partners in Japan, Korea, China, and India in order to benefit from the growing market and increasing interest in model-based development and ISO 26262 in Asia. Asia: Driving force in the automotive industry The automotive industry continues
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia Equipping Asia’s navies with the latest diving technology for asymmetric warfare and operations SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting
UDT Asia 2011
Clarion Events hosts the Undersea Defence Technology (UDT) Asia 2011 conference and exhibition to bring senior naval and industry personnel together to cover underwater developments in the region Singapore, May 30 – Clarion Events is hosting UDT Asia on 30 November – 1 December 2011. The event brings together the undersea defence community in Asia, featuring top regional naval speakers, who will be addressing the latest underwater requirements for Asian navies. According